GLI1 and cancer: This multifaceted inhibition of the SHH/GLI1 pathway translates into tangible anti-cancer effects, including suppressed cell proliferation, colony formation, and migration, and increased apoptosis, partially mediated through the mitochondrial pathway, as evidenced by an increased Bax/Bcl2 ratio [105].